PUBLISHER: IMARC | PRODUCT CODE: 1519642
PUBLISHER: IMARC | PRODUCT CODE: 1519642
Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2024-2032
The global prenatal and newborn genetic testing market size reached US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.5 Billion by 2032, exhibiting a growth rate (CAGR) of 11.5% during 2024-2032. The prenatal and newborn genetic testing market share is experiencing steady growth driven by the growing demand for advanced diagnostic and screening devices, the thriving medical industry, and the rising prevalence of congenital malformations and genetic abnormalities in newborn babies.
Prenatal and Newborn Genetic Testing Market Analysis:
Major Market Drivers: The increasing demand for prenatal and newborn genetic testing and a growing medical industry are driving the prenatal and newborn genetic testing market growth.
Key Market Trends: Key trends include increasing adoption of genetic testing for personalized medicine in prenatal and newborn care. This is positively impacting the prenatal and newborn genetic testing market trends.
Geographical Trends: North America leads the prenatal and newborn genetic testing market demand due to the growing number of pregnant women undergoing genetic screening. The prenatal and newborn genetic testing market forecast for Asia Pacific is also expected to witness growth.
Competitive Landscape: Abbott Laboratories and BGI Group are some of the prenatal and newborn genetic testing market companies driving the prenatal and newborn genetic testing market revenue.
Challenges and Opportunities: Challenges include ethical and legal considerations. The prenatal and newborn genetic testing market recent opportunities lie in the integration of AI and ML technologies.
Prenatal and Newborn Genetic Testing Market Trends:
High Prevalence of Genetic Diseases in Infants
The fetuses in the womb are affected by several genetic disorders. The inheritance pattern of these genetic illnesses has a role in determining both the chance of recurrence and the risk they pose during pregnancy. Babies that have a parent with a chromosomal anomaly, a family history of genetic disorders, or another kid who has a genetic disease are more likely to have genetic diseases. Infants are significantly more likely to be affected by hereditary disorders. Furthermore, these illnesses are to blame for infant mortality worldwide. For example, the World Health Organization predicted that 7.9 million babies worldwide are born with genetic abnormalities. Therefore, the high prevalence of genetic diseases in infants is driving the prenatal and newborn genetic testing market outlook.
Technological advancements
The growth of the prenatal and newborn genetic testing market report is mostly due to advancements in technology. A number of significant advancements, such as non-invasive prenatal testing and next-generation sequencing, have improved the quality of the screening procedure while maintaining safety requirements that guarantee accuracy and improved outcomes. Furthermore, it is highly recommended that the healthcare industry use these innovations to detect and identify a larger range of genetic abnormalities. It also makes sure that the expectant parents decide what's best for the health and safety of their unborn child. Furthermore, a significant improvement has been made, which raises the transformations' authenticity and dependability.
Increasing awareness and demand
The prenatal and newborn genetic testing market overview has experienced an incredible expansion due to the growing awareness and demand for prenatal and newborn genetic testing. These days, the value of early genetic screening is being recognized by more people, including expectant parents and healthcare professionals. The market's need for innovation has increased as a result of this. By using this innovation, a person can learn about genetic abnormalities that are still present and take timely preventative action to reduce the risk to the lives of the babies. With regard to the health and safety of their unborn child, pregnant parents are capable of making the best decisions. Researchers and investors from all over the world have been drawn to the testing services due to their increasing demand.
Prenatal and Newborn Genetic Testing Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the prenatal and newborn genetic testing market statistics, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, screening, disease, and end user.
Breakup by Product Type:
Consumables
Instruments
Consumables account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the product type. This includes consumables and instruments. According to the report, consumables represented the largest segment.
Consumables like testing kits and reagents are fueling the prenatal and newborn genetic testing market recent developments. These kits are really important for checking if babies have any genetic problems before they're born or right after they're born. Also, new technology is making these tests better and easier to do. As more people want these tests, the market for the supplies needed for them is growing, too. Doctors need these supplies to offer good genetic testing services. So, these supplies are a big part of why prenatal and newborn genetic testing is becoming more popular and helpful for families.
Breakup by Screening:
Non-invasive Prenatal Testing
Chorionic Villus Sampling
Amniocentesis
Maternal Serum Screening
Non-invasive prenatal testing holds the largest share of the industry
A detailed breakup and analysis of the market based on the screening have also been provided in the report. This includes non-invasive prenatal testing, chorionic villus sampling, amniocentesis, and maternal serum screening. According to the report, non-invasive prenatal testing accounted for the largest market share.
NIPT is the best way to check babies before they're born. It doesn't require taking samples from the womb. It depends on simple blood tests from the mother. This method is safer and more comfortable. It offers accurate results in detecting genetic conditions like Down syndrome. It doesn't involve any complications associated with invasive techniques. Due to these benefits, more expecting parents are opting for NIPT. It's the top choice for prenatal testing as it's convenient, safe, and gives reliable results.
Breakup by Disease:
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
Downs syndrome represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the disease. This includes downs syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. According to the report, downs syndrome represented the largest segment.
The largest prenatal and newborn genetic testing market recent price is held by Down syndrome testing. An additional copy of chromosome 21 causes this disorder. It is essential for aspiring parents to get tested for Down syndrome in order to plan for any particular care their child may require. The accuracy and accessibility of Down syndrome diagnostics have increased due to technological breakthroughs. Pregnant women are choosing these tests more frequently in order to protect the health of their unborn child. Furthermore, these examinations are advised by medical professionals as standard prenatal care. There is a large demand for testing, which has led to its dominance in the genetic testing market.
Breakup by End User:
Hospital
Maternity and Specialty Clinics
Diagnostic Centers
Hospital represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospital, maternity and specialty clinics, and diagnostic centers. According to the report, hospital represented the largest segment.
Hospitals are at the top of the market. They are essential in the provision of many medical services, such as genetic testing. Patients seeking genetic testing services prefer hospitals as they are dependable and convenient. Hospitals provide accurate testing and appropriate counselling for patients and their families since they have highly qualified staff and modern facilities. Hospitals also frequently work with medical specialists to provide proper care. People are drawn to hospitals due to their reputation for providing high-quality healthcare services. They thereby lead the market share, confirming their status as the main suppliers of genetic testing services.
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest prenatal and newborn genetic testing market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
With a sizable portion of the global market for prenatal and newborn genetic testing, North America currently has a prominent position. The prenatal and newborn genetic testing market has strengthened its position in the region due to a significant number of companies operating in the diagnostics and screening sectors, in addition to the region's increased prevalence of genetic abnormalities and a huge pool of highly aware parents. Also, an increasing number of expecting mothers in this area are having their genetics screened, which supports the market's expansion. The strong purchasing power and growing public knowledge are anticipated to fuel market expansion. For example, March 21st is designated as World Down Syndrome Day each year to raise awareness of the diagnosis and care of individuals with Down syndrome.
Leading Key Players in the Prenatal and Newborn Genetic Testing Industry:
The market for prenatal and newborn genetic testing is expanding rapidly due to the major companies' creativity, innovation, teamwork, and cutting-edge technology. Some of the biggest businesses are constantly working to improve the testing process's quality and safety. The key players are primarily concerned with growing the test panels' capacity to screen for and identify genetic diseases. Additionally, the market for prenatal and newborn genetic testing is expanding at an even faster rate with the help of technological advancements. Furthermore, accessibility and flexibility are guaranteed through partnerships with regulatory bodies and the healthcare industry. Both the expecting parents and their newborns greatly benefit from prenatal and newborn genetic testing.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Abbott Laboratories
BGI Group
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche AG
Illumina Inc.
Laboratory Corporation of America Holdings
Natera Inc.
PerkinElmer Inc.
Quest Diagnostics Incorporated
Ravgen Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Latest News:
April 2, 2024: Abbott Laboratories received FDA approval for the TriClip(TM) transcatheter edge-to-edge repair (TEER) system that's designed for the treatment of tricuspid regurgitation (TR).
March 3, 2023: BGI Group partnered with Science Exchange to offer a 5% discount on its Next Generation Sequencing Services.
April 8, 2024: Bio-Rad Laboratories Inc. announces a collaboration with Allegheny Health Network (AHN), a western Pennsylvania-based integrated healthcare system, to generate clinical evidence across a range of cancer types to support the implementation of Bio-Rad's Droplet Digital(TM) PCR (ddPCR(TM)) technology for tumor-informed molecular residual disease (MRD) monitoring of patients with solid tumor cancer following curative-intent treatment.
Key Questions Answered in This Report:
- How has the global prenatal and newborn genetic testing market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global prenatal and newborn genetic testing market?
- What is the impact of each driver, restraint, and opportunity on the global prenatal and newborn genetic testing market?
- What are the key regional markets?
- Which countries represent the most attractive prenatal and newborn genetic testing market?
- What is the breakup of the market based on the product type?
- Which is the most attractive product type in the prenatal and newborn genetic testing market?
- What is the breakup of the market based on the screening?
- Which is the most attractive screening in the prenatal and newborn genetic testing market?
- What is the breakup of the market based on the disease?
- Which is the most attractive disease in the prenatal and newborn genetic testing market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the prenatal and newborn genetic testing market?
- What is the competitive structure of the market?
- Who are the key players/companies in the global prenatal and newborn genetic testing market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Prenatal and Newborn Genetic Testing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Consumables
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Screening
- 7.1 Non-invasive Prenatal Testing
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Chorionic Villus Sampling
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Amniocentesis
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Maternal Serum Screening
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Disease
- 8.1 Downs Syndrome
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Phenylketonuria
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Cystic Fibrosis
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Sickle Cell Anemia
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospital
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Maternity and Specialty Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Diagnostic Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
- 11.1 Overview
- 11.2 Drivers
- 11.3 Restraints
- 11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 BGI Group
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Bio-Rad Laboratories Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 F. Hoffmann-La Roche AG
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Illumina Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Laboratory Corporation of America Holdings
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Natera Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 PerkinElmer Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Quest Diagnostics Incorporated
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Ravgen Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.1 Abbott Laboratories
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Prenatal and Newborn Genetic Testing Market: Major Drivers and Challenges
- Figure 2: Global: Prenatal and Newborn Genetic Testing Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Product Type (in %), 2023
- Figure 5: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Screening (in %), 2023
- Figure 6: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Disease (in %), 2023
- Figure 7: Global: Prenatal and Newborn Genetic Testing Market: Breakup by End User (in %), 2023
- Figure 8: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Region (in %), 2023
- Figure 9: Global: Prenatal and Newborn Genetic Testing (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Prenatal and Newborn Genetic Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Prenatal and Newborn Genetic Testing (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Prenatal and Newborn Genetic Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Prenatal and Newborn Genetic Testing (Hospital) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Prenatal and Newborn Genetic Testing (Hospital) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: North America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: North America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: United States: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: United States: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Canada: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Canada: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Asia-Pacific: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Asia-Pacific: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: China: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: China: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Japan: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Japan: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: India: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: India: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: South Korea: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: South Korea: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Australia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Australia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Indonesia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Indonesia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Europe: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Europe: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Germany: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Germany: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: France: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: France: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: United Kingdom: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: United Kingdom: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Italy: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Italy: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Spain: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Spain: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Russia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Russia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Latin America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Latin America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Brazil: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Brazil: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Mexico: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Mexico: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Breakup by Country (in %), 2023
- Figure 83: Middle East and Africa: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 84: Global: Prenatal and Newborn Genetic Testing Industry: Drivers, Restraints, and Opportunities
- Figure 85: Global: Prenatal and Newborn Genetic Testing Industry: Value Chain Analysis
- Figure 86: Global: Prenatal and Newborn Genetic Testing Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Prenatal and Newborn Genetic Testing Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
- Table 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Screening (in Million US$), 2024-2032
- Table 4: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Disease (in Million US$), 2024-2032
- Table 5: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 6: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Prenatal and Newborn Genetic Testing Market: Competitive Structure
- Table 8: Global: Prenatal and Newborn Genetic Testing Market: Key Players
